Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial

J Am Coll Cardiol. 2008 Jan 22;51(3):328-9. doi: 10.1016/j.jacc.2007.10.014.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine A2 Receptor Agonists*
  • Adenosine A2 Receptor Antagonists
  • Caffeine / pharmacology*
  • Coronary Circulation / drug effects*
  • Cross-Over Studies
  • Double-Blind Method
  • Drug Interactions
  • Heart Rate / drug effects
  • Humans
  • Positron-Emission Tomography
  • Purines / pharmacology*
  • Pyrazoles / pharmacology*
  • Vasodilator Agents / pharmacology*

Substances

  • Adenosine A2 Receptor Agonists
  • Adenosine A2 Receptor Antagonists
  • Purines
  • Pyrazoles
  • Vasodilator Agents
  • regadenoson
  • Caffeine